Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Sequential oxidative dearomatization/asymmetric homologation: from simple naphthols to chiral benzocycloheptanes

Hongkun Zeng , Shiyang Li , Lichao Ning , Tao Huang , Xiaoming Feng * and Lili Lin *
Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu 610064, China. E-mail: xmfeng@scu.edu.cn; lililin@scu.edu.cn

Received 3rd August 2025 , Accepted 15th October 2025

First published on 16th October 2025


Abstract

An oxidative dearomatization/asymmetric ring-expansion sequential approach is reported to synthesize chiral benzocycloheptanes from unfunctionalized simple β-naphthols under mild reaction conditions. This protocol integrates a copper-catalyzed oxidative dearomatization of β-naphthols, following a chiral N,N′-dioxide-Sc(III) complex-promoted enantioselective homologation with α-diazoesters in one pot, enriching the chemistry of naphthol dearomatization. Computational studies demonstrate the process of Lewis acid-promoted homologation, as well as the origin of stereoselectivity.


Introduction

Chiral benzocycloheptanes, characterized by the fusion of one or two benzene rings with a seven-membered ring, constitute a pivotal structural motif in numerous pharmaceuticals and bioactive natural products.1 For example, as dibenzocycloheptane-type compounds, allocolchicine functions as a tubulin-binding agent with potent activity against a broad spectrum of cancer cell lines;2 dihyisosubamol demonstrates inhibitory activity against α-glucosidase type IV from Bacillus stearothermophilus (Scheme 1a).3 Meanwhile, as mono-benzocycloheptane-type compounds, (R)-ar-himachalene functions as a male-specific aggregation pheromone, serving as a vital scientific tool for monitoring and managing economically important insect pests;4 Hamigeran G exhibits potent anticancer and antitumor properties (Scheme 1b).5 While numerous synthetic strategies for benzocycloheptane have been developed,6 reports focusing on asymmetric catalysis remain remarkably scarce. In 2021, Ramasastry's group reported a chiral phosphine-catalyzed intramolecular asymmetric Morita–Baylis–Hillman reaction of enone-aldehydes, enabling the construction of dibenzocycloheptanes with moderate enantioselectivities.7 In 2023, Chauhan and coworkers reported a bifunctional squaramide-catalyzed domino Michael/nitroaldol reaction between enone-aldehydes with β-keto compounds,8 achieving chiral dibenzocycloheptanes in high efficiency (Scheme 1a). In 2025, Douglas disclosed an enantioselective transient directing group-mediated intramolecular hydroacylation approach to access chiral benzosuberones, enabled by cooperative Rh- and chiral 2-aminopyridine catalysis (Scheme 1b).9 Developing other efficient protocols for the synthesis of chiral benzocycloheptanes, especially starting from simple feedstocks, holds significant merit.
image file: d5sc05865a-s1.tif
Scheme 1 Strategies for the synthesis of chiral benzocycloheptanes.

Naphthols are important chemical materials and synthetic intermediates.10 The oxidative dearomatization of naphthols efficiently furnishes benzocyclic carbonyl compounds.11 On the other hand, diazo compounds serve as versatile synthons for one-carbon chain extension of carbonyl compounds via homologation reactions.12 This process involves nucleophilic addition of the diazomethine carbon to the carbonyl carbon, followed by a 1,2-shift with nitrogen extrusion, enabling chain or ring expansion. We envisioned that in situ generation of 1,2-naphthoquinone from β-naphthol via oxidative dearomatization,13 followed by an asymmetric ring-expansion reaction with an α-diazoester catalyzed by a chiral Lewis acid, would furnish a novel approach to benzocycloheptane construction. The challenges inherent to this strategy are twofold: (1) the oxidant or redox byproducts might interfere with the subsequent asymmetric homologation reaction; (2) the Lewis acid catalyst could promote decomposition of the in situ-generated naphthoquinone. Notwithstanding these hurdles, this tandem strategy holds promise as an efficient approach to constructing chiral benzocycloheptanes from simple starting materials.

Herein, we report the development of a Cu(I)/Sc(III) bimetallic catalytic system14 that efficiently promotes the sequential15 oxidative dearomatization/asymmetric homologation reaction of unfunctionalized β-naphthols with α-diazoesters, thereby enabling a novel strategy for the asymmetric synthesis of benzocycloheptanes (Scheme 1c).

Results and discussion

We initiated our investigation by employing β-naphthol A1 and α-diazoester B1 as model substrates to optimize the reaction conditions. Following the catalytic reaction, o-diaminobenzene was introduced in a one-pot procedure to form quinoxaline C1, which is stable and facilitates chromatographic analysis (Table 1). Firstly, different oxidants were evaluated. No oxidative dearomatization product D1 was observed when Oxone or TEMPO was used as the oxidant (entries 1 and 2). While IBX enabled the formation of D1, the subsequent homologation reaction was completely inhibited with L3-TqPr2/Sc(OTf)3 as the chiral Lewis acid catalyst (entry 3). This inhibition is presumably due to the in situ generation of 2-iodobenzoic acid during the oxidation process, which may exert a detrimental effect on the catalyst activity. Gratifyingly, the combined CuBr/TBHP oxidation system not only afforded D1 efficiently but also furnished the desired product C1 in 38% yield with 81% ee (entry 4). The screening of copper salts revealed that CuCl outperformed both CuBr and CuCl2 in terms of reaction yield (entries 5 and 6). According to the 1H NMR analysis, the yield of D1 was quantified to be 84%.
Table 1 Optimization of the reaction conditionsa

image file: d5sc05865a-u1.tif

Entry Oxidative condition Mn+ Ligand Yield of C1b (%) Ee of C1c (%)
a Reaction conditions: β-naphthol A1 (0.1 mmol), oxidant (0.1 mmol), EA (1.0 mL), 30 °C, 16 h; then ligand/M(OTf)n (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%), α-diazoester B1 (0.12 mmol), DCE (1.0 mL), 30 °C, 12 h; then o-diaminobenzene (1.5 equiv.), 30 °C, 1 h. b Yields of isolated products. c Ee was determined by UPC2 analysis on a chiral stationary phase. d [Cu] (10 mol%), TBHP (4.0 equiv.), 2 h. e DCM instead of DCE. Oxone = potassium monopersulphate triple salt. TBHP = tert-butyl hydroperoxide. IBX = 2-iodoxybenzoic acid. TEMPO = 2,2,6,6-tetramethylpiperidinooxy. N.R. = no reaction.
1 Oxone Sc(OTf)3 L3-TqPr2 N.R.
2 TEMPO Sc(OTf)3 L3-TqPr2 N.R.
3 IBX Sc(OTf)3 L3-TqPr2 0
4d CuBr/TBHP Sc(OTf)3 L3-TqPr2 38 81
5d CuCl/TBHP Sc(OTf)3 L3-TqPr2 50 83
6d CuCl2/TBHP Sc(OTf)3 L3-TqPr2 43 81
7d CuCl/TBHP Cu2+, Ln3+, Al3+ L3-TqPr2 0
8d CuCl/TBHP Sc(OTf)3 L3-RaPr2 31 95
9d CuCl/TBHP Sc(OTf)3 L3-PrPr2 28 80
10d CuCl/TBHP Sc(OTf)3 L3-PiPr2 48 80
11d CuCl/TBHP Sc(OTf)3 L2-RaPr2 42 96
12d CuCl/TBHP Sc(OTf)3 0
13d CuCl/TBHP L2-RaPr2 0
14d,e CuCl/TBHP Sc(OTf)3 L2-RaPr2 57 97


Subsequently, the reaction parameters for the asymmetric homologation were systematically explored. First, a range of metal salts in combination with L3-TqPr2 were screened. While Sc(OTf)3 emerged as the optimal Lewis acid catalyst, other metal salts such as Cu(OTf)2, Ln(OTf)3, and Al(OTf)3 failed to promote the reaction (entry 7). Next, the structural effects of the chiral N,N′-dioxide ligand were investigated. The results indicated that L-ramipril-derived L3-RaPr2 provided superior enantioselectivity compared to other amino acid-derived ligands, though the yield remained low (entries 8–10). Fine-tuning the linker length between the two N-oxide units revealed that a shorter linker not only enhanced the reaction efficiency but also maintained high enantioselectivity (entry 11, 42% yield, 96% ee). Control experiments confirmed that in the absence of a ligand, 1,2-naphthoquinone D1 rapidly decomposed under Sc(OTf)3 catalysis, and no desired product C1 was detected;16 whereas the homologation reaction did not occur in the absence of Sc(OTf)3 (entries 12 and 13). Solvent screening further revealed that switching from DCE to DCM significantly improved the yield (entry 14, 57% yield, 97% ee). Despite extensive optimization efforts, further enhancement of the reaction yield remained elusive due to the inherent instability of D1 under the reaction conditions and competing side reactions involving 1,2-carbonyl migration. Ultimately, the optimal conditions were established using CuCl/TBHP as the oxidant for oxidative dearomatization, Sc(OTf)3/L2-RaPr2 as the Lewis acid catalyst for asymmetric homologation, and 1.2 equiv. of B1 in DCM at 30 °C.

With the optimized conditions established, the substrate scope was explored (Scheme 2). For benzyl diazoesters, variations in electronic properties had minimal impact on reaction efficiency and enantioselectivity. Both electron-donating groups (e.g., Me, tBu, Ph, OMe, and SMe) and electron-withdrawing substituents (e.g., halogen, CO2Me, OCF3, and SCF3) at the para-position of the phenyl ring furnished the products C1–C13 in 32–57% yields with 93–97% ee. The 3-methylbenzyl derivative B14 afforded C14 in 50% yield and 95% ee, whereas the 2-methylbenzyl analogue B15 exhibited significantly reduced reactivity, presumably due to steric hindrance during the reaction. Fused-ring and heterocyclic diazoesters also provided the desired seven-membered ring products with moderate yields and excellent ee (C16–C18, 52–58% yield, 94–96% ee). Linear extension of the benzyl chain (B19–B20) maintained high enantioselectivity (95% and 91% ee, respectively). Substitution with a cinnamyl moiety was also suitable, and C21 was obtained in 52% yield with 95% ee. Terpene-derived diazoesters B22–B23 reacted smoothly, and notably, n-octadecane-derived diazoester B24 was also compatible, providing the corresponding product in 50% yield and 90% ee. Evaluation of ester substituents (B25–B29) revealed that bulky groups (e.g., cyclopentyl, 2-ethylbutyl, cyclopropylmethyl, cyclopentylmethyl, and cyclohexylmethyl) had little effect on the enantioselectivity (C25–C29, 42–52% yield, 92–94% ee).


image file: d5sc05865a-s2.tif
Scheme 2 Substrate scope.a aReaction conditions: β-naphthol A (0.1 mmol), CuCl (10 mol%) and TBHP (4.0 equiv.) in EA (1.0 mL) at 30 °C for 2 h; then L2-RaPr2/Sc(OTf)3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%) and α-diazoester B (0.12 mmol) in DCM (1.0 mL) at 30 °C for 12 h; then o-diaminobenzene (0.15 mmol) at 30 °C for 1 h. Isolated yield. Ee was determined by HPLC or UPC2 on a chiral stationary phase. bL2-RaPr2/Sc(OTf)3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%) and α-diazoester B (0.12 mmol) in DCM (1.0 mL) at 30 °C for 24 h. cIsolated as a mixture of regiosomers.

Next, the scope of β-naphthols was explored. β-Naphthols bearing various functional groups at the C6-position were found compatible with the reaction conditions, smoothly furnishing the corresponding products (C30–C35, 92–98% ee). Generally, substrates containing electron-donating groups (e.g., Et, Ph, and OMe) provided higher yields than those with electron-withdrawing groups (e.g., Br, CO2Me, and CN). The 6-styryl substituted substrate B36 afforded product C36 in 38% yield with excellent enantioselectivity. Additionally, C7-functionalized substrates underwent the reaction efficiently, yielding the target compounds in moderate yields with outstanding ee values (C37–C39, 50–59% yield, 94–97% ee). The absolute configuration of product C4 was unambiguously determined to be (S) by X-ray crystallographic analysis.17

The use of unsymmetric o-diaminobenzene resulted in the formation of two regioisomers. For instance, 4-methyl-1,2-phenylenediamine furnished an inseparable C40/C40′ regioisomer mixture (combined yield: 60%, 97%/96% ee, rr = 46[thin space (1/6-em)]:[thin space (1/6-em)]54). C4-position substitution with an electron-withdrawing Cl group was tolerated, albeit with reduced reactivity (C41/C41′: 19%/23% yield, 97%/91% ee, rr = 45[thin space (1/6-em)]:[thin space (1/6-em)]55). Additionally, C2-position substituents—whether electron-donating (Me) or electron-withdrawing (Cl)—delivered target products in moderate yields: C42/C42′ (20%/30% yield, 97%/91% ee, rr = 40[thin space (1/6-em)]:[thin space (1/6-em)]60) and C43/C43′ (27%/21% yield, 97%/87% ee, rr = 56[thin space (1/6-em)]:[thin space (1/6-em)]44).

Upon treatment with alcohols in place of o-phenylenediamine following the homologation reaction, hemiketal compounds could be obtained in moderate yields with excellent stereoselectivity (Scheme 3, F1–F3, 42–45% yield, 97% ee, >20[thin space (1/6-em)]:[thin space (1/6-em)]1 dr).


image file: d5sc05865a-s3.tif
Scheme 3 Synthesis of chiral hemiketal compounds.a aReaction conditions: A1 (0.1 mmol), CuCl (10 mol%) and TBHP (4.0 equiv.) in EA (1.0 mL) at 30 °C for 2 h; then L2-RaPr2/Sc(OTf)3 (1[thin space (1/6-em)]:[thin space (1/6-em)]1, 10 mol%) and B1 (0.12 mmol) in DCM (1.0 mL) at 30 °C for 12 h; then ROH (0.5 mmol) and K2CO3 (0.5 mmol) at 30 °C for 3 h. Isolated yield. Ee was determined by UPC2 on a chiral stationary phase. Dr was determined by 1H NMR. b ROH (0.5 mmol) and K2CO3 (0.5 mmol) at 30 °C for 5 h.

To demonstrate the synthetic utility of this methodology, a scaled-up synthesis and functional group transformations of compound C1 were conducted. Under optimized conditions, β-naphthol A1 (5.0 mmol) reacted smoothly with α-diazoester B1, furnishing product C1 in 60% yield with 93% ee (Scheme 4a). Subsequent reduction of C1 with Pd/C in MeOH at 60 °C effectively hydrogenated the C[double bond, length as m-dash]C bond, yielding compound F4 in 99% yield. The methoxycarbonyl group was selectively reduced by DIBAL-H in toluene at 50 °C, affording alcohol F5 in 82% yield. Notably, there was no loss of optical purity in the products throughout these transformations (Scheme 4b).


image file: d5sc05865a-s4.tif
Scheme 4 (a) Scale-up synthesis of C1; (b) further transformations.

The reaction mechanism of the Lewis acid-promoted homologation was analyzed through a detailed computational study, as depicted in the reaction energy profile (Scheme 5). The catalytic process initiates with the formation of intermediate INT1, wherein the Sc(III)/L2-RaPr2 complex coordinates to D1 in a bidentate manner,18 generating the initial complex INT1. Subsequently, the alkyl diazoester B1 initiates a nucleophilic attack on the more electropositive carbonyl carbon of D1, leading to the formation of intermediate INT2via transition state TS1. The energy barrier for the formation of the S-configured product (TS1-S) in this process is 1.3 kcal mol−1 lower than that for the formation of the R-configured product (TS1-R). Structure analysis reveals that in TS1-S, there is a CH–π interaction between the phenyl group in B1 and the phenyl group of the ligand. Subsequently, the ring-expansion reaction occurs via transition state TS2, featuring a relatively low activation barrier of 3.3 kcal mol−1, ultimately releasing the product and regenerating the catalyst.


image file: d5sc05865a-s5.tif
Scheme 5 DFT-calculated Gibbs free energy profile for the asymmetric homologation step, showing structures and relative Gibbs free energies of TS1-S and TS1-R.

Conclusions

In summary, we have successfully developed an efficient oxidative dearomatization/asymmetric homologation reaction for non-functionalized β-naphthols. This methodology integrates a copper-catalyzed oxidative dearomatization reaction of β-naphthols with a chiral N,N′-dioxide-ScIII complex-promoted enantioselective homologation reaction of α-diazoesters in a one-pot procedure. A series of valuable optically active benzocycloheptane derivatives were synthesized in moderate to good yields with excellent ee values. The synthetic utility is further validated by scale-up synthesis and post-reaction functional group transformations. Notably, this stepwise strategy enriched the chemistry of naphthol desymmetrization.

Data availability

CCDC 2429703 (C4) contains the supplementary crystallographic data for this paper.19

Supplementary information: 1H, 13C{1H} and 19F{1H} NMR, HPLC and UPC2 spectra (PDF). See DOI: https://doi.org/10.1039/d5sc05865a.

Author contributions

H. K. Z. performed the experiments. L. C. N. conducted the DFT calculation. S. Y. L. participated in the synthesis of substrates. T. H. repeated the experiments to validate the data. X. M. F and L. L. L. supervised the project. H. K. Z. and L. L. L. co-wrote the manuscript.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

We appreciate the National Key R&D Program of China (2023YFA1506700) and the National Natural Science Foundation of China (No. 22171189) for financial support. We are grateful to Dr Yuqiao Zhou from the College of Chemistry, Sichuan University, for the X-ray single crystal diffraction analysis.

Notes and references

  1. (a) J.-H. Fan, Y.-J. Hu, L.-X. Li, J.-J. Wang, S.-P. Li, J. Zhao and C.-C. Li, Nat. Prod. Rep., 2021, 38, 1821–1851 RSC; (b) M. Leblanc and K. Fagnou, Org. Lett., 2005, 7, 2849–2852 CrossRef CAS; (c) K. C. Nicolaou, T. R. Wu, Q. Kang and D. Y.-K. Chen, Angew. Chem., Int. Ed., 2009, 48, 3440–3443 CrossRef CAS; (d) K. C. Nicolaou, Q. Kang, T. R. Wu, C. S. Lim and D. Y.-K. Chen, J. Am. Chem. Soc., 2010, 132, 7540–7548 CrossRef CAS PubMed; (e) S. A. Snyder, T. C. Sherwood and A. G. Ross, Angew. Chem., Int. Ed., 2010, 49, 5146–5150 CrossRef CAS PubMed; (f) J. Li, P. Yang, M. Yao, J. Deng and A. Li, J. Am. Chem. Soc., 2014, 136, 16477–16480 CrossRef CAS PubMed; (g) D. J. Paymode and C. V. Ramana, ACS Omega, 2017, 2, 5591–5600 CrossRef CAS; (h) S. S. Goh, G. Chaubet, B. Gockel, M. Caroline, A. Cordonnier, H. Baars, A. W. Phillips and E. A. Anderson, Angew. Chem., Int. Ed., 2015, 54, 12618–12621 CrossRef CAS PubMed.
  2. (a) G. Micheletti, M. Poli, P. Borsotti, M. Martinelli, B. Imberti, G. Taraboletti and R. Giavazzi, Cancer Res., 2003, 63, 1534 CAS; (b) T. Graening and H. G. Schmalz, Angew. Chem., Int. Ed., 2004, 43, 3230–3256 CrossRef.
  3. H.-C. Lin and S.-S. Lee, J. Nat. Prod., 2012, 75, 1735–1743 CrossRef.
  4. S. P. Chavan and H. S. Khatod, Tetrahedron: Asymmetry, 2012, 23, 1410–1415 CrossRef.
  5. E. F. Woolly, A. J. Singh, E. R. Russell, J. H. Miller and P. T. Northcote, J. Nat. Prod., 2018, 81, 387–393 CrossRef PubMed.
  6. (a) L. F. Silva Jr, R. S. Vasconcelos and M. A. Nogueira, Org. Lett., 2008, 10, 1017–1020 CrossRef PubMed; (b) U. K. Tambar and B. M. Stoltz, J. Am. Chem. Soc., 2005, 127, 5340–5341 CrossRef PubMed; (c) S. B. L. Silva, A. D. Torre, J. E. de Carvalho, A. L. T. G. Ruiz and L. F. Silva Jr, Molecules, 2015, 20, 1475–1494 CrossRef PubMed; (d) Y. Xia, S. Ochi and G. B. Dong, J. Am. Chem. Soc., 2019, 141, 13038–13042 CrossRef PubMed; (e) Q. Y. Yao, L. K. Kong, M. D. Wang, Y. Yuan, R. Z. Sun and Y. Z. Li, Org. Lett., 2018, 20, 1744–1747 CrossRef PubMed; (f) H. Okawa, T. Kawasaki-Takasuka and K. Mori, Org. Lett., 2024, 26, 1662–1666 CrossRef; (g) Y. Otawa and K. Mori, Chem. Commun., 2019, 55, 13856–13859 RSC; (h) M. Kataoka, Y. Otawa, N. Ido and K. Mori, Org. Lett., 2019, 21, 9334–9338 CrossRef PubMed; (i) F. Bodinier, Y. Sanogo, J. Ardisson, M.-I. Lannou and G. Sorin, Chem. Commun., 2021, 57, 3603–3606 RSC; (j) D. Pflästerer, E. Rettenmeier, S. Schneider, E. de Las Heras Ruiz, M. Rudolph and A. S. K. Hashmi, Chem.–Eur. J., 2014, 20, 6752–6755 CrossRef; (k) B. Kramer and S. R. Waldvogel, Angew. Chem., Int. Ed., 2004, 43, 2446–2449 CrossRef PubMed; (l) K. Hackeloer, G. Schnakenburg and S. R. Waldvogel, Org. Lett., 2011, 13, 916–919 CrossRef; (m) W. Q. Kong, N. Fuentes, A. G. Domínguez, E. Merino and C. Nevado, Angew. Chem., Int. Ed., 2015, 54, 2487–2491 CrossRef; (n) Z. M. Xing, B. W. Fang, S. W. Luo, X. G. Xie and X. L. Wang, Org. Lett., 2022, 24, 4034–4039 CrossRef; (o) T. Kikuchi, K. Yamada, T. Yasui and Y. Yamamoto, Org. Lett., 2021, 23, 4710–4714 CrossRef.
  7. A. M. Shivangi, P. Tung, S. V. Wagulde and S. S. V. Ramasastry, Chem. Commun., 2021, 57, 9260–9263 RSC.
  8. N. Kotwal, Tamanna, A. Changotra and P. Chauhan, Org. Lett., 2023, 25, 7523–7528 CrossRef.
  9. P. B. Staub, H. M. Holst, N. N. Puthalath and C. J. Douglas, ACS Catal., 2025, 15, 11512–11518 CrossRef.
  10. (a) M. Weber, M. Weber and M. Kleine-Boymann, Phenol, in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, Germany, 2004, vol. 56, p. 503 Search PubMed; (b) F. Visioli, A. Poli and C. Galli, Med. Res. Rev., 2002, 22, 65–75 CrossRef PubMed.
  11. (a) C.-X. Zhuo, W. Zhang and S.-L. You, Angew. Chem., Int. Ed., 2012, 51, 12662–12686 CrossRef PubMed; (b) R. Kumar, F. V. Singh, N. Takenaga and T. Dohi, Chem.–Asian J., 2022, 17, e202101115 CrossRef PubMed; (c) H. Y. Zhang, N. Xu, R. P. Tang and X. L. Shi, Chin. J. Org. Chem., 2023, 43, 3784–3805 CrossRef; (d) M. F. McLaughlin, E. Massolo, S. B. Liu and J. S. Johnson, J. Am. Chem. Soc., 2019, 141, 2645–2651 CrossRef PubMed.
  12. For the reviews, see: (a) M. P. Doyle, M. A. McKervey and T. Ye, Modern Catalytic Methods for Organic Synthesis with Diazo Compounds, Wiley, New York, 1998 Search PubMed; (b) Y. Zhang and J. B. Wang, Chem. Commun., 2009, 36, 5350–5361 RSC; (c) N. R. Candeias, R. Paterna and P. M. P. Gois, Chem. Rev., 2016, 116, 2937–2981 CrossRef; (d) S. X. Dong, X. H. Liu and X. M. Feng, Acc. Chem. Res., 2022, 55, 415–428 CrossRef , For the selected examples of homologation reactions, see: ; (e) T. Hashimoto, Y. Naganawa and K. Maruoka, J. Am. Chem. Soc., 2011, 133, 8834–8837 CrossRef PubMed; (f) V. L. Rendina, D. C. Moebius and J. S. Kingsbury, Org. Lett., 2011, 13, 2004–2007 CrossRef PubMed; (g) W. Li, X. H. Liu, X. Y. Hao, Y. F. Cai, L. L. Lin and X. M. Feng, Angew. Chem., Int. Ed., 2012, 51, 8644–8647 CrossRef; (h) W. Li, F. Tan, X. Y. Hao, G. Wang, Y. Tang, X. H. Liu, L. L. Lin and X. M. Feng, Angew. Chem., Int. Ed., 2015, 54, 1608–1611 CrossRef; (i) W. Li, X. H. Liu, F. Tan, X. Y. Hao, J. F. Zheng, L. L. Lin and X. M. Feng, Angew. Chem., Int. Ed., 2013, 52, 10883–10886 CrossRef; (j) X. F. Li, P. P. He, P. Zhu, Y. H. Tang and Y. G. Peng, Org. Chem. Front., 2023, 10, 1564–1569 RSC; (k) S.-S. Li, S. Sun and J. B. Wang, Angew. Chem., Int. Ed., 2022, 61, e202115098 CrossRef CAS; (l) H.-M. Jeong, J. W. Lee, D. K. Kim and D. H. Ryu, ACS Catal., 2024, 14, 131–137 CrossRef CAS; (m) S. Y. Li, C. F. Zhang, G. H. Pan, L. K. Yang, Z. S. Su, X. M. Feng and X. H. Liu, ACS Catal., 2023, 13, 4656–4666 CrossRef CAS.
  13. (a) M. Uyanik, T. Mutsuga and K. Ishihara, Molecules, 2012, 17, 8604–8616 CrossRef CAS PubMed; (b) J. Sim, H. Jo, M. Viji, M. Choi, J.-A. Jung, H. Lee and J.-K. Jung, Adv. Synth. Catal., 2018, 360, 852–858 CrossRef CAS; (c) A. K. Mishra and J. N. Moorthy, J. Org. Chem., 2016, 81, 6472–6480 CrossRef CAS PubMed; (d) A. H. Wu, Y. Z. Duan, D. W. Xu, T. M. Penning and R. G. Harvey, Tetrahedron, 2010, 66, 2111–2118 CrossRef CAS PubMed.
  14. (a) D. R. Pyea and N. P. Mankad, Chem. Sci., 2017, 8, 1705–1718 RSC; (b) J. Xu, G. Y. Wang, K. L. Ding and X. M. Wang, J. Am. Chem. Soc., 2025, 147, 2000–2009 CrossRef CAS; (c) Z.-J. Jia, G. Shan, C. G. Daniliuc, A. P. Antonchick and H. Waldmann, Angew. Chem., Int. Ed., 2018, 57, 14493–14497 CrossRef CAS; (d) H. X. Huo, G. L. Li, X. Wang and W. B. Zhang, Angew. Chem., Int. Ed., 2022, 61, e202210086 CrossRef; (e) X. P. Sang, W. T. Xu, Y. Q. Zhou, M. Chen, L. L. Lin, M. H. Ji, F. Wang, S. X. Dong and X. M. Feng, Sci. China: Chem., 2025, 68, 5007–5015 CrossRef CAS.
  15. (a) Q.-J. Liang, Y.-H. Xu and T.-P. Loh, Org. Chem. Front., 2018, 5, 2765–2768 RSC; (b) Z. W. Wu, X. M. Feng and Y. B. Liu, Synthesis, 2024, 56, 3349–3364 CrossRef CAS.
  16. S. X. Dong, W. D. Cao, M. P. Pu, X. H. Liu and X. M. Feng, CCS Chem., 2023, 5, 2717–2735 CrossRef CAS.
  17. CCDC munbers 2429703 (C4) contains the supplementary crystallographic data for this paper.
  18. (a) F. Tan, M. P. Pu, J. He, J. Z. Li, J. Yang, S. X. Dong, X. H. Liu, Y. D. Wu and X. M. Feng, J. Am. Chem. Soc., 2021, 143, 2394–2402 CrossRef CAS; (b) W. D. Cao, X. H. Liu and X. M. Feng, Chin. Sci. Bull., 2020, 65, 2941–2951 CrossRef; (c) H. K. Zeng, G. Weng, L. L. Lin and X. M. Feng, Chem. Commun., 2024, 60, 7507–7510 RSC; (d) J. Q. Tan, L. Q. Yang, H. Y. Su, Y. T. Yang, Z. W. Zhong, X. M. Feng and X. H. Liu, Chem. Sci., 2024, 15, 16050–16058 RSC; (e) L. L. Lin, Y. Q. Zhou, W. D. Cao, S. X. Dong, X. H. Liu and X. M. Feng, Sci. Sin.: Chim., 2023, 53, 246–258 Search PubMed.
  19. CCDC 2429703: Experimental Crystal Structure, 2025,  DOI:10.5517/ccdc.csd.cc2mk9j1..

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.